Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue.
Brewer
George J
GJ
D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications*; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D008708:Methemoglobinemia / Q000150:complications* / Q000188:drug therapy; D008751:Methylene Blue / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D013882:Thiosemicarbazones / Q000008:administration & dosage / Q000009:adverse effects*
D004791:Enzyme Inhibitors; D011725:Pyridines; D013882:Thiosemicarbazones; C078157:3-aminopyridine-2-carboxaldehyde thiosemicarbazone; D008751:Methylene Blue